Opinion

Video

Impact of IPF on Quality of Life and Financial Considerations

Key Takeaways

  • IPF severely impacts quality of life, limiting daily activities due to progressive respiratory decline.
  • Median survival for IPF patients is approximately 3 to 5 years post-diagnosis.
SHOW MORE

Toby Maher, MD, PhD, discusses how idiopathic pulmonary fibrosis (IPF) severely affects patients’ quality of life and daily functioning, with a median survival that underscores the disease’s severity, while also highlighting the substantial financial burden and health care resource utilization associated with managing this condition.

Related Videos
Justin Oldham, MD, MS, an expert on IPF
Screenshot of Stephanie Hsia, PharmD
Cesar Davila-Chapa, MD
1 KOL is featured in this series.
Female doctor in coat with stethoscope on blue background - Pixel-Shot - stock.adobe.com
Anna-Maria Hoffmann-Vold, MD, PhD, a senior consultant and leader of inflammatory and fibrotic research area at Oslo University Hospital
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo